MDT

98.5

+2.11%↑

A

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

MDT

98.5

+2.11%↑

A

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

MDT

98.5

+2.11%↑

A

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

MDT

98.5

+2.11%↑

A

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

MDT

98.5

+2.11%↑

A

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

Search

Accuray Inc

Fermé

SecteurSoins de santé

0.83 -1.19

Résumé

Variation du prix de l'action

24h

Actuel

Min

0.82

Max

0.86

Chiffres clés

By Trading Economics

Revenu

-23M

-22M

Ventes

-34M

94M

Marge bénéficiaire

-23.076

Employés

990

EBITDA

-21M

-10M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+365.12% upside

Dividendes

By Dow Jones

Prochains Résultats

4 févr. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-59M

99M

Ouverture précédente

2.02

Clôture précédente

0.83

Sentiment de l'Actualité

By Acuity

50%

50%

151 / 361 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bullish Evidence

Accuray Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

14 janv. 2026, 22:41 UTC

Acquisitions, Fusions, Rachats

Canadian Natural Resources, Tourmaline File Deal Notice With Antitrust Regulator

15 janv. 2026, 00:00 UTC

Résultats

Welcome to Greenland, an Economy Reliant on Subsidies and Shrimp -- WSJ

14 janv. 2026, 23:47 UTC

Market Talk

Oil Slips After Trump Appears to Tilt Away From Military Action in Iran -- Market Talk

14 janv. 2026, 23:44 UTC

Market Talk

Nikkei May Decline After Hitting Record Highs; Election in Focus -- Market Talk

14 janv. 2026, 23:39 UTC

Market Talk

ANZ's New Bull Still Sees Valuation Gap to Peers -- Market Talk

14 janv. 2026, 23:32 UTC

Market Talk

Gold Declines on Likely Technical Correction, Possible Profit-Taking -- Market Talk

14 janv. 2026, 22:56 UTC

Acquisitions, Fusions, Rachats

Soho House Amends Rollover and Support Agreements With Broad Street Principal Investments and Others

14 janv. 2026, 22:53 UTC

Acquisitions, Fusions, Rachats

Soho House: Apollo Global Management and Goldman Sachs Asset Management Amend Debt Commitment

14 janv. 2026, 22:17 UTC

Market Talk

Global Equities Roundup: Market Talk

14 janv. 2026, 22:17 UTC

Market Talk

WiseTech's Revenue Growth Drivers Attract Scrutiny -- Market Talk

14 janv. 2026, 22:09 UTC

Résultats

CITIC Securities: Uptrend in China Capital Markets Supported Results >600030.SH

14 janv. 2026, 22:08 UTC

Résultats

CITIC Securities 2025 Oper Rev CNY74.83B Vs. CNY58.12B >600030.SH

14 janv. 2026, 22:08 UTC

Résultats

CITIC Securities 2025 Net CNY30.05B Vs. Net CNY21.57B >600030.SH

14 janv. 2026, 21:53 UTC

Acquisitions, Fusions, Rachats

WuXi XDC Expects 2025 Net to Increase Over 38% on Year

14 janv. 2026, 21:53 UTC

Acquisitions, Fusions, Rachats

WuXi XDC Expects 2025 Revenue to Increase More Than 45% on Year

14 janv. 2026, 21:52 UTC

Acquisitions, Fusions, Rachats

WuXi XDC Announces Positive Profit Alert for 2025

14 janv. 2026, 21:51 UTC

Acquisitions, Fusions, Rachats

Citigroup Acting as Financial Advisor to WuXi XDC

14 janv. 2026, 21:51 UTC

Acquisitions, Fusions, Rachats

WuXi XDC: Aims to Keep Listing Status of BioDlink

14 janv. 2026, 21:51 UTC

Acquisitions, Fusions, Rachats

WuXi XDC: Company to Finance BioDlink Shares Acquisition via Internal Resources

14 janv. 2026, 21:50 UTC

Market Talk
Résultats

Financial Services Roundup: Market Talk

14 janv. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

14 janv. 2026, 21:49 UTC

Acquisitions, Fusions, Rachats

WuXi XDC: BioDlink Offer to Cost HK$2.79B

14 janv. 2026, 21:48 UTC

Acquisitions, Fusions, Rachats

WuXi XDC Offers to Pay HK$4.00 for Each BioDlink International Share

14 janv. 2026, 21:48 UTC

Acquisitions, Fusions, Rachats

WuXi XDC Makes Cash Offer for BioDlink International

14 janv. 2026, 21:13 UTC

Market Talk

Oil Retreats Late After Trump Comments on Iran -- Market Talk

14 janv. 2026, 20:30 UTC

Market Talk
Résultats

Danaher's Preliminary 4Q Seen as Promising -- Market Talk

14 janv. 2026, 20:13 UTC

Market Talk

U.S. Natural Gas Futures Sink Ahead of Storage Report -- Market Talk

14 janv. 2026, 20:08 UTC

Market Talk

Oil Futures Extend Rally on Iran Tensions -- Market Talk

14 janv. 2026, 19:33 UTC

Market Talk

Nutrien Seen as Winner in Tighter 2026 Potash Market, Higher Prices -- Market Talk

14 janv. 2026, 19:06 UTC

Market Talk
Résultats

Wells Fargo Says Customers, Economy Remain Resilient -- Market Talk

Comparaison

Variation de prix

Accuray Inc prévision

Objectif de Prix

By TipRanks

365.12% hausse

Prévisions sur 12 Mois

Moyen 4 USD  365.12%

Haut 4 USD

Bas 4 USD

Basé sur 1 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

1 ratings

1

Achat

0

Maintien

0

Vente

Score Technique

By Trading Central

1.28 / 1.61Support & Résistance

Court Terme

Strong Bullish Evidence

Moyen Terme

Strong Bearish Evidence

Long Terme

Bearish Evidence

Sentiment

By Acuity

151 / 361Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Accuray Inc

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.
help-icon Live chat